Abstract
The essence of the Artificial Intelligence (AI) decision system is that it helps us to make a better clinical plan and improve decision efficiency. Mature systems need data, core algorithms, and good interface support. Based on the cancer database of the Chinese Society of Clinical Oncology and the domestic core algorithm, we created the AI decision system with independent intellectual property rights using I ~ IVphases of clinical trials and research. To verify the accuracy of the system, we need assistance from doctors at different levels. The promotion of this system will further improve the standardized diagnosis and treatment of breast cancer and provide guidance for the establishment and application of other intelligent decision-making systems.
Keywords: Artificial Intelligence System, Clinical oncology, Clinical validation, I-IV phase clinical trial.
Related Journals
Related Books
Andrology: Current and Future Developments
Male Infertility: An Integrative Manual of Western and Chinese Medicine
Awake Thoracic Surgery
The Anatomical Foundations of Regional Anesthesia and Acute Pain Medicine Macroanatomy Microanatomy Sonoanatomy Functional anatomy
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents